Anavex Life Sciences Corp (AVXL)

[Investor2014]

You could of course be right that the results, despite the apparent 'breadcrumbs', are not superior after all.

Although I understand Missling's argument that the Rett trial may be the fastest and most cost effective route to market, I've always thought it a risky strategy too. If that trial fails I should think the game is pretty much over as far as share price and funding is concerned.

On the other hand rationally it makes sense not to prolong a looming failure and indeed also, as many will be hoping (including me), to aim straight for the moonshot.

Only more time well tell!